TALEN

TALEN1-lnx2a

ID

ZDB-TALEN-160323-2

Name

TALEN1-lnx2a

Previous Names

None

Target

lnx2a (1)

Target Sequence 1

5' - GGAGGCCCTTTGCTCTGAA - 3'

Target Sequence 2

5' - GGTTCTCCCAGGTGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
y447	lnx2a
y448	lnx2a

Expression

Gene expression in Wild Types + TALEN1-lnx2a

No data available

Phenotype

Phenotype resulting from TALEN1-lnx2a

No data available

Phenotype of all Fish created by or utilizing TALEN1-lnx2a

Phenotype	Fish	Conditions	Figures
exocrine pancreas ptf1a expression decreased amount, abnormal	lnx2a^y447/y447	control	Fig. 5 from Won et al., 2015
exocrine pancreas development decreased process quality, abnormal	lnx2a^y447/y447	standard conditions	Fig. S5 from Won et al., 2015
exocrine pancreas prss1 expression decreased distribution, abnormal	lnx2a^y447/y447	control	Fig. 5 from Won et al., 2015
exocrine pancreas ptf1a expression decreased amount, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas mnx2a expression decreased distribution, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas ptf1a expression decreased amount, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas development disrupted, abnormal	lnx2a^y447/y447	control	Fig. 4 , Fig. 5 from Won et al., 2015
exocrine pancreas development disrupted, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas development disrupted, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas ptf1a expression decreased distribution, abnormal	lnx2a^y447/y447	control	Fig. 4 , Fig. 5 from Won et al., 2015
exocrine pancreas ptf1a expression decreased distribution, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas prss1 expression decreased amount, abnormal	lnx2a^y447/y447	control	Fig. 5 from Won et al., 2015
exocrine pancreas ptf1a expression decreased distribution, abnormal	lnx2a^y447/y447	control	Fig. 4 from Won et al., 2015
exocrine pancreas development process quality, ameliorated	lnx2a^y447/y447 + MO4-numb	control	Fig. 5 , Fig. S5 from Won et al., 2015
exocrine pancreas prss1 expression amount, ameliorated	lnx2a^y447/y447 + MO4-numb	control	Fig. 5 from Won et al., 2015
exocrine pancreas prss1 expression spatial pattern, ameliorated	lnx2a^y447/y447 + MO4-numb	control	Fig. 5 from Won et al., 2015
exocrine pancreas ptf1a expression amount, ameliorated	lnx2a^y447/y447 + MO4-numb	control	Fig. 5 from Won et al., 2015
exocrine pancreas ptf1a expression spatial pattern, ameliorated	lnx2a^y447/y447 + MO4-numb	control	Fig. 5 from Won et al., 2015
exocrine pancreas prss1 expression decreased distribution, abnormal	lnx2a^y448/y448 + MO4-lnx2b	control	Fig. 3 from Won et al., 2015
exocrine pancreas prss1 expression decreased amount, abnormal	lnx2a^y448/y448 + MO4-lnx2b	control	Fig. 3 from Won et al., 2015
exocrine pancreas development decreased process quality, abnormal	lnx2a^y448/y448 + MO4-lnx2b	control	Fig. 3 from Won et al., 2015

Citations